HUTCHMED Announces NDA Acceptance in China for Sovleplenib
— NDA accepted and granted Priority Review following its Breakthrough Therapy designation granted in January 2022 — — NDA is ...
Read more— NDA accepted and granted Priority Review following its Breakthrough Therapy designation granted in January 2022 — — NDA is ...
Read more- ATTRibute-CM demonstrated a significant treatment effect of acoramidis on the primary endpoint (a hierarchical analysis inclusive of all-cause mortality ...
Read moreBOSTON, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights ...
Read moreLondon, UK, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Pandoshi is rapidly emerging as a noteworthy player in the cryptocurrency arena, ...
Read moreVALENCIA, Calif., Jan. 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a commercial-stage regenerative ...
Read moreRoseland, NJ, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The NFT Gaming Company, Inc. ("NFTG" or the "Company"), today announced that ...
Read moreHAMILTON, Ontario, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the ...
Read morePR N°C3225C STMicroelectronics announces new organization New organization to deliver enhanced product development innovation and efficiency, time-to-market as well as ...
Read moreMIAMI, Jan. 09, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (the “Company”) today announced the closing of its ...
Read moreSHANGHAI, China, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.